• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于荧光共振能量转移(FRET)系统的荧光成像法定量微球药物释放

Quantification of Microsphere Drug Release by Fluorescence Imaging with the FRET System.

作者信息

Chen Yuying, Lu Huangjie, He Qingwei, Yang Jie, Lu Hong, Han Jiongming, Zhu Ying, Hu Ping

机构信息

College of Pharmacy, Jinan University, Guangzhou 511436, China.

International School, Jinan University, Guangzhou 511436, China.

出版信息

Pharmaceutics. 2024 Jul 31;16(8):1019. doi: 10.3390/pharmaceutics16081019.

DOI:10.3390/pharmaceutics16081019
PMID:39204364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11360167/
Abstract

Accurately measuring drug and its release kinetics in both in vitro and in vivo environments is crucial for enhancing therapeutic effectiveness while minimizing potential side effects. Nevertheless, the real-time visualization of drug release from microspheres to monitor potential overdoses remains a challenge. The primary objective of this investigation was to employ fluorescence imaging for the real-time monitoring of drug release from microspheres in vitro, thereby simplifying the laborious analysis associated with the detection of drug release. Two distinct varieties of microspheres were fabricated, each encapsulating different drugs within PLGA polymers. Cy5 was selected as the donor, and Cy7 was selected as the acceptor for visualization and quantification of the facilitated microsphere drug release through the application of the fluorescence resonance energy transfer (FRET) principle. The findings from the in vitro experiments indicate a correlation between the FRET fluorescence alterations and the drug release profiles of the microspheres.

摘要

在体外和体内环境中准确测量药物及其释放动力学对于提高治疗效果同时将潜在副作用降至最低至关重要。然而,实时可视化微球中的药物释放以监测潜在的药物过量仍然是一项挑战。本研究的主要目的是利用荧光成像对微球在体外的药物释放进行实时监测,从而简化与药物释放检测相关的繁琐分析。制备了两种不同的微球,每种微球在PLGA聚合物中包裹不同的药物。选择Cy5作为供体,选择Cy7作为受体,通过应用荧光共振能量转移(FRET)原理对微球药物的促进释放进行可视化和定量。体外实验结果表明FRET荧光变化与微球的药物释放曲线之间存在相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/6f28226d0dab/pharmaceutics-16-01019-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/483a79442f62/pharmaceutics-16-01019-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/4bc8038b0703/pharmaceutics-16-01019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/88de37f9ef03/pharmaceutics-16-01019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/aefd09ad1097/pharmaceutics-16-01019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/802bb9792707/pharmaceutics-16-01019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/f5b3c639aa57/pharmaceutics-16-01019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/cde196d85a81/pharmaceutics-16-01019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/0bc822aa2095/pharmaceutics-16-01019-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/6f28226d0dab/pharmaceutics-16-01019-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/483a79442f62/pharmaceutics-16-01019-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/4bc8038b0703/pharmaceutics-16-01019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/88de37f9ef03/pharmaceutics-16-01019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/aefd09ad1097/pharmaceutics-16-01019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/802bb9792707/pharmaceutics-16-01019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/f5b3c639aa57/pharmaceutics-16-01019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/cde196d85a81/pharmaceutics-16-01019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/0bc822aa2095/pharmaceutics-16-01019-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b3/11360167/6f28226d0dab/pharmaceutics-16-01019-g008.jpg

相似文献

1
Quantification of Microsphere Drug Release by Fluorescence Imaging with the FRET System.基于荧光共振能量转移(FRET)系统的荧光成像法定量微球药物释放
Pharmaceutics. 2024 Jul 31;16(8):1019. doi: 10.3390/pharmaceutics16081019.
2
Visualization and correlation of drug release of risperidone/clozapine microspheres in vitro and in vivo based on FRET mechanism.基于荧光共振能量转移(FRET)机制的利培酮/氯氮平微球体外与体内药物释放的可视化与相关性研究。
Int J Pharm. 2024 Mar 25;653:123885. doi: 10.1016/j.ijpharm.2024.123885. Epub 2024 Feb 6.
3
Visualization of the degradation of long-acting microneedles and correlation of drug release in vivo based on FRET mechanism.基于荧光共振能量转移(FRET)机制的长效微针降解可视化及体内药物释放相关性研究
Acta Biomater. 2024 Dec;190:152-164. doi: 10.1016/j.actbio.2024.10.016. Epub 2024 Oct 12.
4
[Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].[利培酮微球/醋酸蔗糖异丁酸酯原位形成具有双重扩散屏障的复合长效注射剂的制备与评价]
Yao Xue Xue Bao. 2015 Jun;50(6):775-82.
5
The effect of PLGA molecular weight differences on risperidone release from microspheres.PLGA 分子量差异对微球中利培酮释放的影响。
Int J Pharm. 2020 May 30;582:119339. doi: 10.1016/j.ijpharm.2020.119339. Epub 2020 Apr 17.
6
An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.具有良好体内体外相关性的利培酮聚乳酸-羟基乙酸共聚物微球速释方法
Curr Drug Deliv. 2018;15(1):87-96. doi: 10.2174/1567201814666170516113406.
7
Microsphere delivery of Risperidone as an alternative to combination therapy.利培酮微球给药作为联合治疗的替代方案。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):631-9. doi: 10.1016/j.ejpb.2013.07.012. Epub 2013 Jul 24.
8
Effect of polymer source variation on the properties and performance of risperidone microspheres.聚合物源变化对利培酮微球性质和性能的影响。
Int J Pharm. 2021 Dec 15;610:121265. doi: 10.1016/j.ijpharm.2021.121265. Epub 2021 Nov 5.
9
In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature.PLGA 微球的体外-体内相关性:聚合物来源变化和温度的影响。
J Control Release. 2022 Jul;347:347-355. doi: 10.1016/j.jconrel.2022.05.014. Epub 2022 May 18.
10
A reproducible accelerated in vitro release testing method for PLGA microspheres.一种用于聚乳酸-羟基乙酸共聚物(PLGA)微球的可重现的加速体外释放测试方法。
Int J Pharm. 2016 Feb 10;498(1-2):274-82. doi: 10.1016/j.ijpharm.2015.12.031. Epub 2015 Dec 15.

本文引用的文献

1
The recent insight in the release of anticancer drug loaded into PLGA microspheres.载药 PLGA 微球的释放的最新见解。
Med Oncol. 2023 Jul 6;40(8):229. doi: 10.1007/s12032-023-02103-9.
2
Evolution of nanomedicine formulations for targeted delivery and controlled release.纳米医学制剂的靶向传递和控制释放的演变。
Adv Drug Deliv Rev. 2023 Sep;200:114962. doi: 10.1016/j.addr.2023.114962. Epub 2023 Jun 13.
3
Selection of an aggregation-caused quenching-based fluorescent tracer for imaging studies in nano drug delivery systems.
用于纳米药物递送系统成像研究的基于聚集猝灭的荧光示踪剂的选择。
Nanoscale. 2023 Jun 1;15(21):9290-9296. doi: 10.1039/d3nr01018j.
4
Potential Polymorphic CYP1A2 and CYP2D6-mediated Pharmacokinetic Interactions between Risperidone or Olanzapine and Selected Drugs Intended to Treat COVID-19.利培酮或奥氮平与某些用于治疗COVID-19的药物之间潜在的多态性CYP1A2和CYP2D6介导的药代动力学相互作用。
Drug Metab Bioanal Lett. 2023;16(1):6-13. doi: 10.2174/1872312815666221125112724.
5
Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances.用于药物递送应用的聚乳酸基微粒:最新进展综述
Pharmaceutics. 2022 Feb 4;14(2):359. doi: 10.3390/pharmaceutics14020359.
6
Alternative Routes of Administration of Clozapine.氯氮平的其他给药途径。
CNS Drugs. 2022 Feb;36(2):105-111. doi: 10.1007/s40263-022-00900-w. Epub 2022 Feb 3.
7
Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone.氯氮平影响利培酮的药代动力学,在体内和体外抑制其代谢和 P-糖蛋白介导的转运:氯氮平和利培酮联合应用时抗精神病药联合用药的安全性注意事项。
Toxicol Appl Pharmacol. 2021 Jul 1;422:115560. doi: 10.1016/j.taap.2021.115560. Epub 2021 May 3.
8
The effect of PLGA molecular weight differences on risperidone release from microspheres.PLGA 分子量差异对微球中利培酮释放的影响。
Int J Pharm. 2020 May 30;582:119339. doi: 10.1016/j.ijpharm.2020.119339. Epub 2020 Apr 17.
9
In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release.聚丙交酯乙交酯微球的体外表征:变异性突释效应的影响
J Control Release. 2019 Nov 28;314:25-37. doi: 10.1016/j.jconrel.2019.10.014. Epub 2019 Oct 22.
10
Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool.实现药物纳米载体更精确的生物成像:变聚集诱导猝灭为有用工具。
Adv Drug Deliv Rev. 2019 Mar 15;143:206-225. doi: 10.1016/j.addr.2019.05.009. Epub 2019 May 31.